FDA.reportPublic FDA data

Ryoncil 25,000,000 CELLS per 3.8 ML Injection

RxCUI
2700778
RxNorm name
Ryoncil 25,000,000 CELLS per 3.8 ML Injection
Display name
Ryoncil 25,000,000 CELLS per 3.8 ML Injection
Full name
Ryoncil 25,000,000 CELLS per 3.8 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125706ryoncilremestemcel-L-rknd351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RYONCILREMESTEMCEL-L-RKNDMesoblasta4e0918f-7444-4694-adeb-d38d983456592025-09-11Warnings, Adverse reactionsExact identifier
rxcui: 2700778

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
a4e0918f-7444-4694-adeb-d38d98345659Ryoncil 25,000,000 CELLS per 3.8 ML InjectionSY5These highlights do not include all the information needed to use RYONCIL ® safely and effectively. See full prescribing information for RYONCIL ® . RYONCIL ® (remestemcel-L-rknd) suspension for intravenous infusion Initial U.S. Approval: December 202420250911
a4e0918f-7444-4694-adeb-d38d983456593.8 ML Ryoncil 6680000 CELLS/ML InjectionSY5These highlights do not include all the information needed to use RYONCIL ® safely and effectively. See full prescribing information for RYONCIL ® . RYONCIL ® (remestemcel-L-rknd) suspension for intravenous infusion Initial U.S. Approval: December 202420250911
a4e0918f-7444-4694-adeb-d38d983456593.8 ML remestemcel-L-rknd 6680000 CELLS/ML Injection [Ryoncil]SBD5These highlights do not include all the information needed to use RYONCIL ® safely and effectively. See full prescribing information for RYONCIL ® . RYONCIL ® (remestemcel-L-rknd) suspension for intravenous infusion Initial U.S. Approval: December 202420250911
a4e0918f-7444-4694-adeb-d38d98345659Ryoncil 25,000,000 CELLS in 3.8 ML InjectionPSN5These highlights do not include all the information needed to use RYONCIL ® safely and effectively. See full prescribing information for RYONCIL ® . RYONCIL ® (remestemcel-L-rknd) suspension for intravenous infusion Initial U.S. Approval: December 202420250911